In summary, our research revealed that NAT10, functioning as a tumor-promoting factor, suppresses ferroptosis in ccRCC via the NFE2L1-GPX4 signaling pathway, thereby facilitating the malignant progression of the disease. The gene discussed is GPX4; the disease is nonpapillary renal cell carcinoma.